Elektra Health’s Post

30 Top Health Tech Startups & Companies To Watch 2024 Noteworthy changes are taking place in the healthcare industry. Many health companies use the newest technology to develop remarkable ideas that will change the field. This tsunami of innovative ideas is changing healthcare delivery and experience. The healthcare market was valued at 7.9 trillion Dollars the previous year. Let's examine 30 innovative health tech startups and enterprises changing this year. for more information, visit; https://lnkd.in/gxaMN55i #owebesttechnology #appdevelopmentcompany #appdevelopment #HealthTech #HealthcareInnovation #MedTech #HealthStartups #DigitalHealth #HealthCareRevolution #TechInHealth #FutureOfHealth #HealthCareTech #HealthInnovation #HealthTech2024 #MedStartups #HealthCareTransformation #SmartHealth #HealthTechNews #HealthCareStartups #InnovativeHealth #HealthTechTrends #HealthTechInnovation #HealthTechCompanies #HealthTechStartups

🇮🇩 Reported by Tech in Asia: "Indonesian healthtech platform Alodokter has raised US$5.2 million. This adds to a US$6 million injection from Optima Health last year. Founded in 2014 by Nathanael Faibis and Suci Arumsari, Alodokter offers an array of healthcare services, including online doctor consultations, in-person appointment booking, and informative articles on health. Its investors include Softbank Ventures Asia, Golden Gate Ventures, and Sequis Life." FemTech Association Asia is watching what impact this has on femtech and women's health in Indonesia through their 2023 acquisition of pregnancy app Diary Bunda. https://lnkd.in/gAuGqmSg #femtechassociationasia #femtech #womenshealth #maternalcare #childcare #mobileapp #app #digitalhealth #platform #digihealth #tracker #health

This is good news for FemTech 🎉 Flo Health Inc. - the world’s most popular female health app - has raised more than $200 million from General Atlantic. This sets the UK-founded company’s valuation at more than $1 billion, making it Europe’s first FemTech unicorn. At the same time, it’s important to consider what this landmark deal says in light of the lack of funding for female founders. Given the investment is into an all-male founding team, when over 70% of FemTech companies have at least one female founder. We hope, however, that it shines a light on the huge potential in this space, along with the sector's many brilliant female founders. And, ultimately, encourages more investment in FemTech startups in the UK and across the globe! You can read more here: https://lnkd.in/eXnWU5m4 #FemTech #Womenshealth

Congratulations to these top 29 Healthcare Technology Startups in Chicago. How about your Startup? Are you in need top C-Suite or Executive Level Talent to make the list? If so, we can help! Message us and let's chat! #shorelinerecruitmentgroup #healthcaretechnologyrecruiting

🌐 Exciting Tech Discoveries: Exploring the Top Startups of 2023 who will probably dominate in 2024 as well🚀 Day 1 🚀, Hey LinkedIn fam! 👋 Today, let's dive into the world of groundbreaking tech startups and shine a spotlight on Peppy, an AI startup making waves in the health sector. 🚀 Peppy : Revolutionizing Digital Health: Founded in London in 2018, Peppy is at the forefront of digital health platforms, addressing critical areas such as menopause, fertility, pregnancy, and overall men's and women's health. What sets them apart? Their services are tailored and individualized, providing personal video consultations and more. 💡 Necessity Meets Innovation: Peppy's journey is a mix of luck and foresight. The surge in digitization during the COVID-19 pandemic pushed employee services online, creating a perfect environment for platforms like Peppy to thrive. 👩⚕️ Tailored Healthcare Anytime, Anywhere: Peppy offers a range of services accessible via a mobile app, including instant messaging, group chat, video consultations, live events, articles, videos, and community participation. Their corporate-focused model provides these services for free to employees. 💰 Funding Milestones: Back in 2021, Peppy raised eyebrows with a $10 million Series A led by Felix Capital. Fast forward to 2023, and they secured an impressive $45 million Series B to expand their B2B2C health services platform to the US. The driving force behind this funding? AlbionVC, a prominent investor in Peppy's latest growth chapter. 📈 Steady Growth Amid Challenges: While Peppy experienced a slight slowdown in growth, they remain a formidable contender in the tech startup arena. Their commitment to innovation and personalized health services positions them as a dynamic player to watch. 🔍 The Journey Continues: As we explore the dynamic landscape of tech startups, Peppy's journey showcases the resilience and adaptability required to stay at the forefront. Keep an eye on them; they're still in the running for the top spot! 👉 Stay tuned for more updates on the tech front as we unravel the stories of innovation and disruption! #TechStartups #Innovation #DigitalHealth #Peppy #AI #StartupJourney #TechTrends2023

The stratified care approach to low back pain (STarTBack) approach generates more than £226 for every £1 spent to implement it, according to a recent report by the RAND corporation https://lnkd.in/dyzVxNzf For more information about STarT Back visit https://lnkd.in/dCCZ7f6C #backpain #startback

Here are some lesser-known facts and insights related to the success, challenges, and business model of Eucalyptus. 1. Unexpected Entry into Weight Loss Market: The founder, Tim Doyle, did not initially anticipate entering the weight loss market. This highlights how startups often adapt and pivot their focus based on market opportunities and demands. 2. Diversification into Healthcare Sectors: Eucalyptus has expanded its offerings into various healthcare sectors, including men's health products and fertility treatments. This diversification strategy can help startups like Eucalyptus capture a broader market. 3. Regulatory Compliance Challenges: The company has faced regulatory challenges related to advertising prescription-only medicines in Australia. This underscores the importance of navigating complex regulatory environments in the healthcare industry. 4. Patient-Centric Approach: Eucalyptus has responded to shortages of its weight loss product, Ozempic, by offering alternative solutions to alleviate patient stress. This patient-centric approach is crucial for maintaining trust and satisfaction. 5. Financial Stability and Growth: Despite challenges, Eucalyptus remains financially stable and is expanding into new markets. This indicates the resilience and growth potential of healthcare startups, even in the face of regulatory hurdles. 6. Online Consultations and Support: Eucalyptus follows a business model that involves online consultations with doctors for prescription medicines and additional support for weight loss, including dietary advice and coaching. This integrated approach aligns with the trend of telehealth and patient engagement. 7. Rejection of Stereotypes: Tim Doyle rejects claims that the company is a "pill mill" or ecommerce drug store. This highlights the need for startups to address any misconceptions and emphasize their commitment to responsible healthcare practices. Pros of Ozempic: Effective Blood Sugar Control: Ozempic is a GLP-1 receptor agonist that helps lower blood sugar levels, improving glycemic control in people with type 2 diabetes. Weight Loss: Ozempic can lead to significant weight loss, which is beneficial for those with diabetes struggling with weight management. Cardiovascular Benefits: It may reduce the risk of major cardiovascular events in people with type 2 diabetes. Lower Risk of Hypoglycemia: Ozempic is associated with a lower risk of low blood sugar. Cons of Ozempic: Cost: It can be expensive and may not be fully covered by insurance. Side Effects: Common side effects include nausea, vomiting, diarrhea, and abdominal pain. Injection: Some may be uncomfortable with self-administered injections. Limited Long-Term Data: Long-term safety and effectiveness data is limited.

This week #femtechfriday FemTech India * Fertility Challenges: Global Average Conception Time 6.8 Years, 4.5 Years in India, Defying WHO Recommendations. * UK Workplace Challenges : 2/3 Women Face Menstrual Symptoms Impact, With 60% Battling Cramps. * NHS Scotland's New Policy Supports Women's Menstrual Health and Menopause Across Workforce. * Generative AI in 2024: Wearables to Revolutionize Personalized Health Experiences and DNA-Based Treatments. * India's Telemedicine Market Hits US$1.9 Billion in 2022, Anticipated to Soar to US$10.7 Billion by 2028. * OECD Report: Digital Health Emerges as a Crucial Health Determinant, Shaping Future Health Systems. 🔽 Read the complete report below and subscribe for weekly updates. #femtechindia #india #femtechnews #womenshealthindia https://lnkd.in/grkexRVj

Record valuation for a woman-led femtech startup. Spring Health, an AI-powered mental health company co-founded by April Koh and Adam Chekroud, just raised a $100 million series E round of financing that valued the company at $3.3 billion. The youngest woman to lead a unicorn startup (value of $1 billion or more), Koh is CEO of Spring. The company sells what it calls “precision mental healthcare” to employers and health plans, offering a service that matches patients with the providers that best meet their needs. With 10 million people having access to the platform, the company has 10,000 providers in its network. Femtech – technology-driven solutions and services centered on women’s health – is a growing sector. Flo Health Inc., a London-based fertility and period tracking app founded by four men, raised $200 million in a Series C round this week, valuing the startup at over $1 billion. The company, which has 70 million users of its free monthly product and 5 million users of its paid version, plans to expand its focus to include perimenopause and menopause. We applaud these femtech providers of women’s health services. More investment in the sector is needed in order to address persistent gender gaps in health care products and services. See bit.ly/GLIQ for our latest analysis of investing in women-led and women-focused businesses in the global economy. This is not an endorsement or recommendation of the highlighted companies or funds. Parallelle Finance has no affiliation with any of the companies or funds mentioned. See additional disclosures at bit.ly/PFDisclosures. Ingrid Lunden General Atlantic Jessie Cai Tanzeen Syed Dmitry Gurski Yuri Gurski Flint Capital #VentureCapital #GenderLensInvesting #InvestingInWomen #InvestingByWomen #FemTech #HealthCare #Unicorn #DiverseLeadership

FemTech app Flo Health Inc. hits unicorn status with $200M Series C raise. 🦄 It's a women's health SaaS founded, led and invested in by men. While I see this as a broad win for women's health, I would love to see more female leadership and investment in an industry that impacts women's very own health. Consider this... 🤯 Women contribute to almost 80% of the $3.6 trillion annual healthcare spend but only make up approximately 13% of CEOs in the healthcare industry. (Mira) 📉 Seed stage women's health companies were consistently valued 20% lower than seed stage health companies overall in 2023. (Innovation in Women's Health Report) 👎🏼 The number of women-led health startups is growing exponentially, yet only accounts for 2% of VC investment. Of that, Black and Latinx women have received just 0.64%. (Mira) But, it’s not all bad news…. 📈 VC investment in women’s health increased 314% over the last five years, outpacing the 28% rise in healthcare overall. (Bloomberg) 🤑 Women-led health startups raised $167 million in funding last year. (Bill and Melinda Gates Foundation) 😲 The average deal size for women’s health companies reached a new high in 2023: $10.4M. (Forbes) Today, let’s raise a glass to Flo and other women's health startups poised to shake up the industry.